Search Results - "AKITA, MAAYA"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
  2. 2
  3. 3

    Ectopic expression of N-acetylglucosaminyltransferase V accelerates hepatic triglyceride synthesis by Kamada, Yoshihiro, Ebisutani, Yusuke, Kida, Sachiho, Mizutani, Kayo, Akita, Maaya, Yamamoto, Akiko, Fujii, Hironobu, Sobajima, Tomoaki, Terao, Naoko, Takamatsu, Shinji, Yoshida, Yuichi, Takehara, Tetsuo, Miyoshi, Eiji

    Published in Hepatology research (01-03-2016)
    “…Aim Glycosylation changes induce various types of biological phenomena in human diseases. N‐Acetylglucosaminyltransferase V (GnT‐V) is one of the most…”
    Get full text
    Journal Article
  4. 4

    Core-fucose-specific Pholiota squarrosa lectin decreased hepatic inflammatory macrophage infiltration in steatohepatitis mice by Kamada, Yoshihiro, Ueda, Yui, Matsuno, Eriko, Matsumoto, Riku, Akita, Maaya, Takamatsu, Shinji, Miyoshi, Eiji

    Published in Glycoconjugate journal (01-10-2024)
    “…Recent findings in glycobiology revealed direct evidence of the involvement of oligosaccharide changes in human diseases, including liver diseases…”
    Get full text
    Journal Article
  5. 5

    Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects by Sato, Motoya, Kamada, Yoshihiro, Takeda, Yuri, Kida, Sachiho, Ohara, Yuka, Fujii, Hironobu, Akita, Maaya, Mizutani, Kayo, Yoshida, Yuichi, Yamada, Makoto, Hougaku, Hidetaka, Takehara, Tetsuo, Miyoshi, Eiji

    Published in Liver international (01-03-2015)
    “…Background & Aims Fetuin‐A (α2HS‐glycoprotein), a liver secretory glycoprotein, is known as a transforming growth factor (TGF)‐β1 signalling inhibitor. Serum…”
    Get full text
    Journal Article
  6. 6

    Abstract 886: Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis by Kamada, Yoshihiro, Mizutani, Kayo, Fujii, Hironobu, Akita, Maaya, Ohara, Yuka, Takamatsu, Shinji, Miyoshi, Eiji

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Background & Aims: Nonalcoholic fatty liver disease (NAFLD) is a growing medical problem around the world. Among NAFLD patients, those with nonalcoholic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis. e66328 by Kamada, Yoshihiro, Akita, Maaya, Takeda, Yuri, Yamada, Shin, Fujii, Hideki, Sawai, Yoshiyuki, Doi, Yoshinori, Asazawa, Hitomi, Nakayama, Kotarosumitomo, Mizutani, Kayo

    Published in PloS one (01-06-2013)
    “…Nonalcoholic fatty liver disease (NAFLD) is a growing medical problem around the world. NAFLD patients with nonalcoholic steatohepatitis (NASH) can develop…”
    Get full text
    Journal Article
  9. 9

    N-Acetylglucosaminyltransferase V exacerbates concanavalin A-induced hepatitis in mice by KAMADA, YOSHIHIRO, SATO, MOTOYA, KIDA, SACHIHO, AKITA, MAAYA, MIZUTANI, KAYO, FUJII, HIRONOBU, SOBAJIMA, TOMOAKI, YOSHIDA, YUICHI, SHINZAKI, SHINICHIRO, TAKAMATSU, SHINJI, TAKEHARA, TETSUO, MIYOSHI, EIJI

    Published in Molecular medicine reports (01-05-2015)
    “…N-Acetylglucosaminyltransferase V (GnT-V) catalyzes β1-6 branching in asparagine-linked oligosaccharides and is one of the most important glycosyltransferases…”
    Get full text
    Journal Article